Data / Drug companies / Topco Associates LLC
Topco Associates LLC: 150 products in the FDA NDC directory, labeler code 76162
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Topco Associates LLC (labeler code 76162) lists 150 products in the FDA National Drug Code Directory, covering 79 finished drugs by generic name. By type: 150 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 24, 2026.
The request: Watch Topco Associates LLC (FDA labeler code 76162): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 76162
- Products in commercial distribution
- 150
- Packages
- 177
- Finished drugs by generic name
- 79
- Prescription products
- 0
- Over the counter products
- 150
- Flagged as original packager
- 145 of 145 products that carry the flag
- Started marketing in the last 12 months
- 28
- Products with a marketing end date set
- 3
- Earliest marketing start
- May 21, 2009
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 121 | 80.7% |
| Generic drugs (ANDA) | 24 | 16% |
| New drug applications (NDA) | 5 | 3.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 150 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 17 | 11.3% |
| Solution | 14 | 9.3% |
| Pastille | 12 | 8% |
| Liquid | 12 | 8% |
| Tablet, chewable | 10 | 6.7% |
| Kit | 8 | 5.3% |
| Tablet, film coated | 7 | 4.7% |
| Mouthwash | 6 | 4% |
| Shampoo | 6 | 4% |
| Gel | 6 | 4% |
| Tablet | 5 | 3.3% |
| Spray | 5 | 3.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Allergy Relief | 76162-915 | Tablet, coated | Generic drugs (ANDA) | September 24, 2026 |
| Adapalene Paraben Free | 76162-221 | Gel | Generic drugs (ANDA) | September 15, 2026 |
| Nicotine Transdermal System step 1 | 76162-742 | Patch, extended release | New drug applications (NDA) | September 1, 2026 |
| Nicotine Transdermal System step 2 | 76162-741 | Patch, extended release | New drug applications (NDA) | September 1, 2026 |
| Nicotine Transdermal System step 3 | 76162-740 | Patch, extended release | New drug applications (NDA) | September 1, 2026 |
| Avobenzone, Homosalate, Octisalate | 76162-947 | Lotion | Over the counter monograph drugs | August 20, 2026 |
| Avebonzone, Homosalate, Octisalate | 76162-979 | Spray | Over the counter monograph drugs | August 6, 2026 |
| Avebonzone, Homosalate, Octisalate | 76162-946 | Spray | Over the counter monograph drugs | August 6, 2026 |
| Avebonzone, Homosalate, Octisalate | 76162-943 | Spray | Over the counter monograph drugs | August 6, 2026 |
| Avobenzone, homosalate, octisalate | 76162-942 | Spray | Over the counter monograph drugs | August 6, 2026 |
| Avobenzone, homosalate, octisalate | 76162-941 | Spray | Over the counter monograph drugs | August 6, 2026 |
| Lidocaine HCl | 76162-034 | Gel | Over the counter monograph drugs | August 5, 2026 |
| Topcare day time cold and flu | 76162-598 | Tablet, film coated | Over the counter monograph drugs | August 4, 2026 |
| Topcare nite time cold and flu | 76162-619 | Tablet, film coated | Over the counter monograph drugs | July 24, 2026 |
| TopCare Health Pain Relief | 76162-982 | Liquid | Over the counter monograph drugs | July 1, 2026 |
| Guaifenesin and dextromethorphan hbr | 76162-032 | Tablet, extended release | Generic drugs (ANDA) | April 23, 2026 |
| Guaifenesin | 76162-031 | Tablet, extended release | Generic drugs (ANDA) | April 22, 2026 |
| Topcare Pain Relief Patch | 76162-999 | Patch | Over the counter monograph drugs | April 9, 2026 |
| Topcare tussin cf max | 76162-198 | Solution | Over the counter monograph drugs | February 11, 2026 |
| Salicylic acid | 76162-414 | Liquid | Over the counter monograph drugs | February 6, 2026 |
| TopCare Pain Relieving Cream | 76162-291 | Cream | Over the counter monograph drugs | January 30, 2026 |
| Homosalate, Octisalate, Zinc oxide | 76162-957 | Lotion | Over the counter monograph drugs | January 22, 2026 |
| Antibacterial | 76162-897 | Liquid | Over the counter monograph drugs | December 18, 2025 |
| Antibacterial | 76162-279 | Liquid | Over the counter monograph drugs | December 18, 2025 |
| ULTRA STRENGTH Gas Relief Softgels | 76162-840 | Capsule, liquid filled | Over the counter monograph drugs | December 17, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.